GIROTEC

This brand name is authorized in South Africa

Active ingredients

The drug GIROTEC contains one active pharmaceutical ingredient (API):

1 Lamotrigine UNII U3H27498KS - LAMOTRIGINE

Lamotrigine is a use and voltage dependent blocker of voltage gated sodium channels. It inhibits sustained repetitive firing of neurons and inhibits release of glutamate (the neurotransmitter which plays a key role in the generation of epileptic seizures). Read about Lamotrigine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GIROTEC Tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AX09	Lamotrigine	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/2.5/0047, 43/2.5/0048, 43/2.5/0049, 43/2.5/0050